Excellence in Research, Education and Outreach
The Rogel Cancer Center is one of only 49 cancer programs in the United States designated by the National Cancer Institute as a Comprehensive Cancer Center. Our excellence in clinical research, laboratory research, education, community outreach, and cancer prevention and control have led to this distinction.
Outstanding Research-Driven Cancer Prevention and Treatment
The Rogel Cancer Center has a distinguished history of scientific excellence, collaboration and impact in basic science, clinical research and cancer control research. Through our focus on team science and research excellence, we aim to be a national leader in prevention, early diagnosis, optimal treatment and survivorship care for those at risk of or affected by cancer. Our mission is to reduce cancer burden and improve cancer outcomes through research, innovation, collaboration, education, outreach and engagement.
Collaboration Leads to Scientific Breakthroughs
Our members, including clinicians, researchers and other scientists, maintain a very collaborative relationship across all areas of the University of Michigan Rogel Cancer Center. Encompassing members from 53 departments across 9 University of Michigan schools, we are harnessing the power of one of the largest, most robust and highly esteemed research universities in the world to create new knowledge about cancer.
Meeting Needs across Expanding Cancer Populations
To meet the needs of the ever-expanding cancer populations, the Rogel Cancer Center has determined overarching initiatives across our research programs:
- Implement innovative initiatives intended to improve our ability to prevent cancer and diagnose cancer at earlier and more treatable stages
- Increase efforts to engage and positively impact the patients and population we serve
- Pursue new cancer education and training initiatives
- Support clinical cancer research more efficiently and effectively
- Treat cancer more effectively with new agents and approaches
Our cancer center has been awarded three Specialized Programs of Research Excellence (SPORE) grants by the National Cancer Institute. These grants, in prostate cancer, gastrointestinal cancers and sarcoma, include both basic and clinical/applied research that focus on:
- Early detection
Shared Resources Supports Advancing Cancer Research
A distinguishing factor of the University of Michigan Rogel Cancer Center is the groundbreaking collection of Shared Resources. Through these extensive resources, entire teams offer our members access to services, technologies and scientific consultations that expedite scientific interactions and strengthen scientific productivity.
These are our Shared Resources:
- Biostatistics Analytics & Bioinformatics
- Cell & Tissue Imaging
- Experimental Irradiation
- Flow Cytometry
- Health Communications
- Immune Monitoring
- Preclinical Imaging and Computational Analysis
- Structure and Drug Screening
- Tissue & Molecular Pathology
- Transgenic Animal Models
Shared Resources serve scientists within the University of Michigan and others from across many other organizations, including international requests. They provide access to and support with comprehensive technical and scientific capabilities. With such strong support across the university, researchers are able to move discovery forward to lessen the burden of cancer and increase quality of life in patients.
Learn more about research at the U-M Rogel Cancer Center